VCCBH News


Whitaker Awarded $1.95M Grant to Unravel Anesthesia-Induced Hypotension

August 31, 2023 by Angela Ferrante

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics, received a substantial R35 MIRA grant from NIGMS for his study “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” This five-year project—the department’s first NIH grant—addresses intraoperative hypotension in neonates, infants, and older adults under anesthesia.

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics at the Larner College of Medicine, has been granted a prestigious R35 MIRA award by the National Institute of General Medical Sciences (NIGMS) in recognition of his groundbreaking research on “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” With an impressive grant of $1.95 million, equivalent to an R01, this funding will propel his investigations over the upcoming five years, focusing on understanding and mitigating intraoperative hypotension—an issue of critical concern among neonates, infants, and older adults undergoing anesthesia.

The unique feature of R35 grants lies in their provision of funding that isn’t confined to specific projects, affording researchers the flexibility to delve into emerging scientific ideas. Known as the Maximizing Investigators’ Research Award program (MIRA) within NIGMS, the R35 grant format has been in existence since 2015.

Whitaker’s research is poised to offer invaluable insights to medical professionals and anesthesiologists, empowering them to identify early intervention opportunities and determine the most efficacious approaches to enhance organ perfusion, transcending the sole emphasis on elevating blood pressure. Within the populations of neonates, infants, and geriatric patients, occurrences of intraoperative hypotension and compromised organ perfusion exceed the norm. While the precise mechanisms responsible for this distinction remain elusive, the pivotal role played by extreme age demographics is strongly inferred. The vascular systems of these diverse groups share several common attributes that may contribute to hypotension.

Whitaker and his dedicated team plan to synergize intact animal models with in vitro methods. This comprehensive approach enables scientists to study blood vessels both under typical conditions and in specific scenarios, facilitating a clear distinction between adjusted cases and controls. Notably, Whitaker emphasized that the factors contributing to this issue can exhibit considerable variability,

He elaborates, “Blood pressure interpretation can be intricate—it’s not an exact science. Optimal blood pressure may coexist with inadequate organ perfusion. Our focus is on comprehending and defining organ perfusion-based hypotension by monitoring blood flow in vital organs, such as the brain, kidneys, and gut. Subsequent induction of hypotension in test subjects enables us, as anesthesiologists, to ascertain the decline in organ blood flow. This knowledge equips us to intervene effectively, before irreversible organ damage occurs.”

Whitaker’s research seeks to evaluate the outcomes of potential interventions, assessing their impact on the target populations. Certain pressure agents, such as norepinephrine, may exhibit superior efficacy in treating anesthesia-induced hypotension compared to alternatives. Furthermore, the team aspires to uncover enhanced strategies for addressing organ perfusion beyond conventional blood pressure-centric treatments.

This research holds exceptional significance for the Larner College of Medicine, constituting a pivotal milestone—this is the first NIH grant awarded to the Department of Anesthesiology. “My colleagues in the department played a pivotal role,” emphasized Whitaker. “Their unwavering support was instrumental in not only laying the groundwork for this award but also in empowering me to achieve it.” This accomplishment highlights Whitaker’s expertise while also underscoring the institution’s dedication to advancing medical understanding and elevating patient care within the realm of anesthesiology.

“The folks at the Vermont Center for Cardiovascular and Brain Health (VCCBH), particularly Drs. Mary Cushman, Marilyn J. Cipolla, and Mark Nelson, played an integral role in securing this esteemed grant opportunity,” reflected Whitaker. “The VCCBH provides an immensely supportive environment. Grants of this caliber serve as crucial mechanisms for enhancing patient care and attracting diverse scientists, clinicians, and students keen on pioneering work in an environment that nurtures their pursuits.” Mary Cushman, M.D., along with Mark Nelson, Ph.D., are co-directors of the VCCBH and Marilyn Cipolla, Ph.D., is a professor of Neurological Sciences.



Recent Stories and Publications Featuring VCCBH Members


Target ALS LinkedIn Post Featuring Research by Dr. Kathryn H. Morelli, PhD

Posted January 4, 2025

"ALS is a devastating disease, but researchers like Kathryn H. Morelli, Ph.D., a Target ALS Springboard Fellow and now an assistant professor at the University of Vermont, are driving innovations that bring us closer to effective treatments. Focused on developing RNA-targeted therapies for C9orf72 ALS, one of the most common genetic causes of the disease, Kathy’s work showcases the critical importance of collaboration, cutting-edge tools, and determination..."

Advancing ALS Research with Stem Cell Resources and Targeted Reagents: The Role of Target ALS in the Quest for Effective Treatment

Posted January 4, 2025

"ALS is a devastating neurodegenerative disease, and while there is no cure, ongoing research continues to offer hope for more effective treatments. An individual at the forefront of these efforts is Dr. Kathryn Morelli, an assistant professor in the Department of Neurological Sciences at the University of Vermont’s Larner College of Medicine, whose research aims to address the complex challenges of ALS, building on work she did with her postdoctoral mentor Dr. Gene Yeo. Working closely with Abby Kirch, a PhD student in her lab, Kathy and her team are focused on developing RNA-targeted therapies for ALS, particularly for the C9ORF72 mutation, one of the most common genetic causes of the disease..."

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted December 4, 2024

"On November 16, Larner Assistant Professor of Medicine Debora Kamin Mukaz, Ph.D., M.S., moderated a panel on science policy advocacy titled “How can we engage scientists from historically underrepresented backgrounds in policymaking and advocacy?” at the American Heart Association’s Scientific Sessions 2024 conference in Chicago. The panelists were AHA President Keith Churchwell, M.D.; past AHA President Michelle Albert, M.D., M.P.H.; Emelia Benjamin, M.D., Sc.M., associate provost and professor of medicine and epidemiology at Boston University; and Carl Streed, Jr., M.D., M.P.H., associate professor of medicine at Boston University..."

Research on spider brain leads to groundbreaking Alzheimer’s discovery

Posted December 3, 2024

"Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains 
Vermont Business Magazine Researchers from Saint Michael’s College and the University of Vermont have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain..."

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

"In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity..."

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

"Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration..."

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

"The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood..."

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

"Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it..."